Based on these data, we aimed at verifying whether the levels of tPA and PAI-1 in the serum of patients with AD dementia and with amnestic mild cognitive impairment (aMCI) due to AD are altered compared to healthy controls and whether they are associated with the severity of cognitive impairment. This evidence concerns the gene PLAT and Cognitive impairment.